Maen Nusair, MD
Interventional Cardiology · Arlington Heights, ILNPI 1942393137
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $9,058 of the $13,655 with a category attached, or 66.3%. 36 manufacturers reported payments, led by Boston Scientific at 25.0% of the total. Reporting peaked in 2022 at $3,802 and has fallen 65.2% since, to $1,322 in 2025.
Across 304 payments — averaging $44.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Edwards Lifesciences$3K
- Philips North America LLC$2K
- Abiomed$827
- Novartis$556
- Amgen$478
- plus $4K from 30 others
Across 2 payments — averaging $2626.10 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Philips North America LLC$5K
What the payments were for
- Consulting fees$1,50011%
- Travel & lodging$3,09723%
- Food & beverage$9,05866%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 32 | $3,416 |
| Edwards Lifesciences | 31 | $2,781 |
| Philips North America LLC | 16 | $1,649 |
| Abiomed | 24 | $827 |
| Novartis | 26 | $556 |
| Amgen | 21 | $478 |
| Medtronic(2 entities) | 20 | $427 |
| Abbott | 14 | $420 |
| Pfizer | 15 | $364 |
| Boehringer Ingelheim | 13 | $319 |
| Biosense Webster, Inc. | 7 | $270 |
| E.r. Squibb & Sons, L.L.C. | 12 | $217 |
| Chiesi USA, Inc. | 9 | $173 |
| Shockwave Medical, Inc | 3 | $172 |
| Surmodics, Inc. | 3 | $161 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 6 | $158 |
| Johnson & Johnson | 7 | $157 |
| AstraZeneca | 8 | $153 |
| Stryker | 4 | $145 |
| Teleflex LLC | 6 | $138 |
| Kiniksa Pharmaceuticals International, PLC | 5 | $130 |
| Kestra Medical Technology Services, Inc. | 3 | $103 |
| Merck | 4 | $82 |
| Livanova USA, Inc. | 2 | $47 |
| Bayer | 2 | $45 |
| Sanofi-aventis U.S. LLC | 1 | $37 |
| Bridgebio Pharma, Inc. | 1 | $36 |
| Inari Medical, Inc. | 1 | $27 |
| Novo Nordisk | 1 | $25 |
| Penumbra, Inc. | 1 | $25 |
| Cordis US CORP. | 1 | $24 |
| Terumo Medical Corporation | 1 | $22 |
| Lantheus Medical Imaging, Inc. | 1 | $20 |
| Acist Medical Systems, Inc. | 1 | $19 |
| Angiodynamics, Inc. | 1 | $18 |
| Cardiva Medical, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Edwards SAPIEN 3 Transcatheter Heart Valve$1,635
- GENERAL VASCULAR ACCESS$1,500
- (9525) Intracardiac Und$1,051
- Watchman$1,027
- AVVIGO Guidance System$279
- Impella$248
- (9520) IGT Devices Undivided$213
- SAPIEN 3 Ultra RESILIA$122
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$112
- (9148) ICE 3D$112
- WATCHMAN Access System$111
- CoreValve Evolut$102
- PASCAL$101
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$101
How this compares
$13,655 in reported general payments places this provider in the 65th percentile of 303 interventional cardiology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 157 | $203,374 |
| XareltoRivaroxaban | 44 | $45,096 |
| EntrestoSacubitril/Valsartan | 26 | $26,946 |
| Repatha SureclickEvolocumab | 23 | $24,341 |
| Repatha SyringeEvolocumab | 14 | $9,692 |
| Metoprolol Succinate | 286 | $3,802 |
| Atorvastatin Calcium | 301 | $2,870 |
| Ezetimibe | 52 | $1,677 |
| VascepaIcosapent Ethyl | 16 | $1,664 |
| Rosuvastatin Calcium | 152 | $1,601 |
| Lisinopril | 127 | $1,149 |
| Metoprolol Tartrate | 173 | $1,025 |
| Amlodipine Besylate | 192 | $1,008 |
| Losartan Potassium | 96 | $662 |
| Furosemide | 99 | $562 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $364 | $203,374157 claims |
| Johnson & JohnsonXarelto | $157 | $45,09644 claims |
| NovartisEntresto | $556 | $26,94626 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 303 interventional cardiology providers in Illinois.
Other interventional cardiology in Arlington Heights
- Andrei PopElk Grove Village$900K
- Atman ShahChicago$788K
- Ravi RamanaPalos Park$458K
- Mahesh RajuDowners Grove$281K
- Mark RicciardiEvanston$253K
- Neal SawlaniPark Ridge$246K
- Tony de MartiniSpringfield$208K
- Bouyella ReddyMoline$172K
- David StewartChicago$169K
- Jaafer GolzarOak Lawn$152K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.